White House says popular weight-loss drug Ozempic subject to Medicare talks
Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.
What's Your Reaction?







Chatty News Dec 7, 2024 0 38
Chatty News Nov 18, 2024 0 35
Chatty News Nov 20, 2024 0 31
Chatty News Nov 26, 2024 0 31
Chatty News Dec 26, 2024 0 28
Chatty News Nov 18, 2024 0 18
Chatty News Nov 18, 2024 0 20
Chatty News Nov 18, 2024 0 20
Total Vote: 5
Yes